MD gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. MD has an average financial health and profitability rating. MD is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings could make MD a good candidate for value investing.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

MD had positive earnings in the past year.
MD had a positive operating cash flow in the past year.
In multiple years MD reported negative net income over the last 5 years.
Each year in the past 5 years MD had a positive operating cash flow.

1.2 Ratios

The Return On Assets of MD (7.37%) is better than 90.20% of its industry peers.
With an excellent Return On Equity value of 18.21%, MD belongs to the best of the industry, outperforming 85.29% of the companies in the same industry.
MD's Return On Invested Capital of 10.25% is fine compared to the rest of the industry. MD outperforms 79.41% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MD is in line with the industry average of 9.21%.
The 3 year average ROIC (7.83%) for MD is below the current ROIC(10.25%), indicating increased profibility in the last year.

		Industry Rank	Sector Rank
ROA	7.37%
ROE	18.21%
ROIC	10.25%

ROA(3y)-1.5%

ROA(5y)-4.7%

ROE(3y)-4.21%

ROE(5y)-20.91%

ROIC(3y)7.83%

ROIC(5y)7.13%

1.3 Margins

With an excellent Profit Margin value of 8.44%, MD belongs to the best of the industry, outperforming 90.20% of the companies in the same industry.
With an excellent Operating Margin value of 12.20%, MD belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
MD's Operating Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	12.2%
PM (TTM)	8.44%
GM	N/A

OM growth 3Y-7.13%

OM growth 5Y-6.94%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MD is creating some value.
The number of shares outstanding for MD has been increased compared to 1 year ago.
Compared to 5 years ago, MD has more shares outstanding
Compared to 1 year ago, MD has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 2.20 indicates that MD is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.20, MD perfoms like the industry average, outperforming 49.02% of the companies in the same industry.
MD has a debt to FCF ratio of 2.20. This is a good value and a sign of high solvency as MD would need 2.20 years to pay back of all of its debts.
MD has a Debt to FCF ratio of 2.20. This is in the better half of the industry: MD outperforms 78.43% of its industry peers.
MD has a Debt/Equity ratio of 0.65. This is a neutral value indicating MD is somewhat dependend on debt financing.
MD has a Debt to Equity ratio (0.65) which is comparable to the rest of the industry.
Although MD does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.

		Industry Rank	Sector Rank
Debt/Equity	0.65
Debt/FCF	2.2
Altman-Z	2.2

ROIC/WACC1.16

WACC8.86%

2.3 Liquidity

MD has a Current Ratio of 1.83. This is a normal value and indicates that MD is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.83, MD is doing good in the industry, outperforming 72.55% of the companies in the same industry.
A Quick Ratio of 1.83 indicates that MD should not have too much problems paying its short term obligations.
MD's Quick ratio of 1.83 is fine compared to the rest of the industry. MD outperforms 75.49% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.83
Quick Ratio	1.83

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 56.92% over the past year.
The earnings per share for MD have been decreasing by -15.01% on average. This is quite bad
MD shows a decrease in Revenue. In the last year, the revenue decreased by -4.21%.
MD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.49% yearly.

EPS 1Y (TTM)56.92%

EPS 3Y-2.95%

EPS 5Y-15.01%

EPS Q2Q%52.27%

Revenue 1Y (TTM)-4.21%

Revenue growth 3Y1.74%

Revenue growth 5Y2.49%

Sales Q2Q%-3.58%

3.2 Future

Based on estimates for the next years, MD will show a small growth in Earnings Per Share. The EPS will grow by 7.64% on average per year.
The Revenue is expected to grow by 2.71% on average over the next years.

EPS Next Y44.07%

EPS Next 2Y22.97%

EPS Next 3Y16.76%

EPS Next 5Y7.64%

Revenue Next Year-4.52%

Revenue Next 2Y-0.98%

Revenue Next 3Y0.1%

Revenue Next 5Y2.71%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.56, the valuation of MD can be described as reasonable.
89.22% of the companies in the same industry are more expensive than MD, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.21, MD is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 9.56, the valuation of MD can be described as reasonable.
Based on the Price/Forward Earnings ratio, MD is valued cheaply inside the industry as 89.22% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.26, MD is valued rather cheaply.

		Industry Rank	Sector Rank
PE	10.56
Fwd PE	9.56

4.2 Price Multiples

MD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MD is cheaper than 83.33% of the companies in the same industry.
MD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MD is cheaper than 89.22% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	6.77
EV/EBITDA	7.47

4.3 Compensation for Growth

MD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of MD may justify a higher PE ratio.
MD's earnings are expected to grow with 16.76% in the coming years. This may justify a more expensive valuation.